Search Results

• • 17 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Radiation-induced coronary artery disease: a second survivorship challenge?

  Authors:Dipti Gupta, Shawn C Pun, Shivani Verma, and Richard M SteingartFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,903 words Report 1830LAuthor(s): Dipti Gupta [*] aff1 aff2 , Shawn C Pun aff1 , Shivani Verma aff1 , Richard M Steingart aff1 aff2 KEYWORDS cancer survivor; radiation The role of adjuvant mediastinal radiation (RT) in improving...

• Cardio-oncology: an ongoing evolution

  Authors:Bradley J Petek, Chris Greenman, Joerg Herrmann, Michael S Ewer, and Robin L JonesFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20155,553 words Report 1930LAuthor(s): Bradley J Petek aff1 , Chris Greenman aff2 , Joerg Herrmann aff3 , Michael S Ewer aff4 , Robin L Jones [*] aff5 KEYWORDS anthracycline; cancer therapy; cardio-oncology; cardiotoxicity In the modern...

• Cardio-oncology: a tremendous opportunity to improve patient care

  From:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,074 words Interview 1260LAuthor(s): Daniel J Lenihan [*] aff1 KEYWORDS anthracyclines; biomarkers; cardio-oncology; cardiotoxicity; radiation; trastuzumab fellowship Q Can you tell our readers about your career to-date & how you came...

• Identifying cancer patients at risk for cardiotoxicity

  Authors:Michela Salvatici and Maria T SandriFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 201510,454 words Report 1860LAuthor(s): Michela Salvatici [*] aff1 , Maria T Sandri aff1 KEYWORDS biomarkers; cardio-oncology; cardiotoxicity; cardiovascular damage; chemotherapy; identification Cardiotoxicity: early identification...

• Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management

  Authors:Alfredo Tartarone, Giuseppina Gallucci, Chiara Lazzari, Rosa Lerose, Lucia Lombardi, and Michele AietaFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20153,152 words Report 1820LAuthor(s): Alfredo Tartarone [*] aff1 , Giuseppina Gallucci aff2 , Chiara Lazzari aff3 , Rosa Lerose aff4 , Lucia Lombardi aff1 , Michele Aieta aff1 KEYWORDS ALK-positive non-small-cell lung cancer; crizotinib;...

• Carotid artery inflammation associated with gemcitabine-based therapy: a special report

  Authors:Alexandre Chan, Mingjun Song, Mark Ryan De Guzman Langit, Teh Aun Lim, Warren Fong, Kevin Tay, et al.From:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20154,724 words Clinical report 1490LAuthor(s): Alexandre Chan aff1 aff2 , Mingjun Song aff3 , Mark Ryan De Guzman Langit aff1 , Teh Aun Lim aff4 , Warren Fong aff5 , Kevin Tay aff3 , Soon Thye Lim aff3 , Tiffany Tang [*] aff3 KEYWORDS carotid...

• Radiation-related heart and vascular disease

  Authors:Syed Wamique Yusuf, Rebecca M Howell, Daniel Gomez, Chelsea C Pinnix, Cezar A Iliescu, and Jose BanchsFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20156,251 words Report 2160LAuthor(s): Syed Wamique Yusuf [*] aff1 , Rebecca M Howell aff2 , Daniel Gomez aff3 , Chelsea C Pinnix aff3 , Cezar A Iliescu aff1 , Jose Banchs aff1 KEYWORDS cardiovascular disease; radiation Advancement in...

• Should the 'echo guidelines' be followed in cancer patients?

  Authors:Joerg Herrmann and Eric H YangFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20153,029 words Report 1900LAuthor(s): Joerg Herrmann [*] aff1 , Eric H Yang aff2 KEYWORDS cardiotoxicity; echocardiography; surveillance Which cardiac monitoring guidelines apply to cancer patients? Never before has this question...

• Should vascular effects of newer treatments be addressed more completely?

  Authors:Eric H Yang, Karol E Watson, and Joerg HerrmannFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,544 words Report 1970LAuthor(s): Eric H Yang [*] aff1 , Karol E Watson aff1 , Joerg Herrmann aff2 KEYWORDS cardio-oncology; cardiotoxicity; dasatinib; imatinib resistance; leukemia; nilotinib; peripheral arterial disease; ponatinib;...

• The discipline of onco-cardiology

  Author:Elie MouhayarFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20151,789 words Report 1730LAuthor(s): Elie Mouhayar [*] aff1 aff2 KEYWORDS cancer survivors; cardiotoxicity; onco-cardiology; targeted therapy; tyrosine kinase inhibitors; vascular toxicity Onco-cardiology is a fast growing medical...

• Cardio-oncology: a special focus issue from Future Oncology

  Authors:Robin L Jones and Maria Teresa SandriFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20151,243 words Editorial 1880LAuthor(s): Robin L Jones [*] aff1 , Maria Teresa Sandri aff2 KEYWORDS cardiology; cardiotoxicity; monitor; oncology; treatment It is a great pleasure to introduce this special focus issue on cardio-oncology....

• Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors

  Authors:Matthew J Ehrhardt, Saro H Armenian, and Joy M FulbrightFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,779 words Report 2550LAuthor(s): Matthew J Ehrhardt aff1 , Saro H Armenian [*] aff2 , Joy M Fulbright aff3 KEYWORDS anthracyclines; cardiac dysfunction; chest radiation; childhood cancer survivors; late effects; prevention; screening;...

• Optimizing cardio-oncology programs for cancer patients

  Authors:Sanjeev A Francis, Aarti Asnani, Tomas Neilan, and Marielle Scherrer-CrosbieFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,503 words Report 1760LAuthor(s): Sanjeev A Francis [*] aff1 , Aarti Asnani aff1 , Tomas Neilan aff1 , Marielle Scherrer-Crosbie aff1 KEYWORDS anthracycline; cardio-oncology; chemotherapy-induced cardiomyopathy; cardiotoxicity;...

• Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers

  Authors:Nausheen Akhter, Gillian Murtagh, and Clyde YancyFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20158,005 words Report 1730LAuthor(s): Nausheen Akhter aff1 , Gillian Murtagh aff2 , Clyde Yancy [*] aff1 KEYWORDS biomarkers; cancer therapeutics-related cardiac dysfunction; cardiovascular MRI; CMR; CTRCD; echocardiography; highly...

• Left ventricular ejection fraction in advanced cancer patients: a valuable prognostic tool?

  Authors:Rabih Said and Apostolia M TsimberidouFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,496 words Report 2410LAuthor(s): Rabih Said aff1 aff2 , Apostolia M Tsimberidou [*] aff1 KEYWORDS cardiomyopathy; cardio-oncology; chemotherapy; LVEF; targeted therapy Left ventricular (LV) systolic function is determined by the...

• The use of myocardial strain and newer echocardiography imaging techniques in cancer patients

  Authors:Husam Abdel-Qadir, Eitan Amir, and Paaladinesh ThavendiranathanFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20153,319 words Report 1910LAuthor(s): Husam Abdel-Qadir aff1 aff2 , Eitan Amir aff3 , Paaladinesh Thavendiranathan [*] aff4 KEYWORDS cardiomyopathies; cardiotoxicity; deformation imaging; early diagnosis; global longitudinal strain; speckle...

• Melatonin: a protective role against doxorubicin-induced cardiotoxicity

  Authors:Jenelle Govender, Ben Loos, and Anna-Mart EngelbrechtFrom:Future Oncology (Vol. 11, Issue 14) Peer-Reviewed

  July 20152,207 words Report 2350LAuthor(s): Jenelle Govender aff1 , Ben Loos aff1 , Anna-Mart Engelbrecht [*] aff1 KEYWORDS cardio-oncology; doxorubicin-induced cardiotoxicity; heart; melatonin; mitochondria Melatonin: a protective role...